Table 4. Clinical details of patients with autoimmune or severe atopic disease.

Case	Cardiac diagnosis	Autoimmune/Atopic disease	Transplant year	Transplant age (years)	Time transplant to symptoms (years)	ATG dose (mg/kg)	Immunosuppression Regimen			Tac level* (ng/ml), Median (IQR)		Rejection
							Initial	At diagnosis	Current	Year one	After year one
1	Dilated cardiomyopathy	Inflammatory bowel disease	2002	0.4	5.5	10.5	Tac, Aza	Tac, Aza	Tac, Aza	10.3 (7.9-13.2)	7 (4.8-10.7)	Yes
2	Dilated cardiomyopathy	Inflammatory bowel disease	2004	0.4	4.8	12	Tac, Aza	Tac, Aza	Tac, Aza	9.6 (6.3-13.8)	6.9 (5.6-8.9)	No
2	Cardiac fibroma	Chronic bullous disease of childhood & Inflammatory bowel disease	2002	0.1	7.9	14	Tac, MMF	Tac, MMF	Tac, Aza	8.5 (7.1-11.5)	6.3 (4.6-8.4)	No
4	Dilated cardiomyopathy	Eosinophilic colitis	2001	0.3	4	13.7	Tac, MMF	Tac, Aza	Tac, MMF	12.4 (8.8-14.9)	7.7 (5.8-10.3)	Yes
5	Dilated cardiomyopathy	Eosinophilic colitis & esophagitis	2007	0.6	1.6	11.8	Tac, MMF	Tac, MMF	Tac, Sir	8 (6.1-10.9)	7.5 (6.2-9.2)	Yes
6	Pulmonary atresia	Eosinophilic esophagitis	2005	0.1	0.6	13.3	Tac, MMF	Tac, MMF	Tac, MMF	8 (6.4-9.3)	5.7 (4.6-7.8)	No
7	Complex single ventricle	Eosinophilic esophagitis	2004	5.1	7.3	3.8	Tac, MMF	Tac, MMF	Tac, Sir	8.7 (6-11.3)	9.1 (6.7-12.5)	Yes

^*Tacrolimus level divided from initial discharge until the end of the first year post-transplant and subsequent to the first year post-transplant, ATG - anti-thymocyte globulin, Aza - azathioprine, IQR - interquartile range, MMF - mycophenolate mofetil, Sir - sirolimus, Tac - tacrolimus